The Brief Memory and Executive Test (BMET) for detecting vascular cognitive impairment in small vessel disease: a validation study.
Repository URI
Repository DOI
Loading...
Type
Change log
Abstract
Cognitive impairment is common in patients with cerebral small vessel disease, but is not well detected using common cognitive screening tests which have been primarily devised for cortical dementias. We developed the Brief Memory and Executive Test (BMET); a rapid screening measure sensitive to the impaired executive function and processing speed characteristic of small vessel disease (SVD). To assess the BMET's validity for general use, we evaluated it when administered by non-psychologists in a multicentre study and collected control data to derive normative scores.
Description
Keywords
32 Biomedical and Clinical Sciences, 42 Health Sciences, Cerebrovascular, Neurodegenerative, Neurosciences, Alzheimer's Disease including Alzheimer's Disease Related Dementias (AD/ADRD), Behavioral and Social Science, Dementia, Brain Disorders, Mental Health, Basic Behavioral and Social Science, Alzheimer's Disease, Stroke, Vascular Cognitive Impairment/Dementia, Clinical Research, Acquired Cognitive Impairment, Aging, Alzheimer's Disease Related Dementias (ADRD), 4.2 Evaluation of markers and technologies, 2.1 Biological and endogenous factors, Mental health, 3 Good Health and Well Being, Adult, Aged, Aged, 80 and over, Cognition Disorders, Female, Humans, Magnetic Resonance Imaging, Male, Middle Aged, Neuropsychological Tests, Reproducibility of Results, Sensitivity and Specificity, Stroke
Journal Title
BMC Med
Conference Name
Journal ISSN
1741-7015
1741-7015
1741-7015
Volume Title
Publisher
Springer Nature
Publisher DOI
Rights and licensing
Except where otherwised noted, this item's license is described as All Rights Reserved
Sponsorship
Stroke Association (TSA BHF 2010/01)
Stroke Association (TSA 2010/08)
Stroke Association (TSA 2010/08)
The BMET study was funded by The Stroke Association (TSA2010/08). Recruitment to BMET was supported by the NIHR Stroke Clinical Research Network. Hugh Markus is supported by an NIHR Senior Investigator award and his work is supported by the Cambridge University Hospitals NIHR Comprehensive BRC. Matthew Hollocks is supported by a Stroke Association/British Heart Foundation Grant (TSA BHF 2010/01). Robin Morris receives consultancy fees for P1Vital Limited. The authors disclose no competing interests financial or otherwise.
